top of page
it's where dermatology lives
John Evans
Nov 11, 20222 min read
Belimumab improves cutaneous lupus erythematosus regardless of systemic lupus
Recent findings show that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether or not...
Allan Ryan
Aug 22, 20222 min read
New monoclonal antibody shows efficacy in CLE
An early study of litifilimab, a humanized monoclonal antibody, has indicated it may be effective in the treatment of cutaneous lupus...
Featured Posts
bottom of page